期刊文献+

P^(15)基因mRNA及其蛋白在原发上皮性卵巢癌中的表达及意义 被引量:1

P^(15) 基因mRNA及其蛋白在原发上皮性卵巢癌中的表达及意义
下载PDF
导出
摘要 目的 探讨原发上皮性卵巢癌中P15基因mRNA(P15mRNA)及其蛋白的表达情况 ,以确定该基因在原发上皮性卵巢癌发生发展过程中的作用。方法 采用逆转录 聚合酶链反应 (RT PCR)及免疫组化方法 ,对4 8例原发上皮性卵巢癌以及 15例正常卵巢组织P15mRNA及其蛋白进行了检测。结果  4 8例原发上皮性卵巢癌中P15mRNA表达缺失者 11例 (2 2 92 % ) ,P15蛋白缺失者 13例 (2 7 0 8% ,包括 11例P15mRNA表达缺失者 )。15例正常卵巢组织P15mRNA及其蛋白均有表达。P15mRNA及其蛋白表达缺失与原发性上皮性卵巢癌的组织学类型有关 (P <0 0 5 ) ,而与其FIGO分期及组织学分级无关 ,但随肿瘤临床期别和病理级别增高缺失率有增高的趋势。一致性检验显示P15mRNA与其蛋白表达关系密切 (P <0 0 5 )。结论 P15基因在原发上皮性卵巢癌中存在mRNA以及蛋白表达的异常 ,提示该基因的失活与原发上皮性卵巢癌的发生有关。 Objective To study the aberrant expression of P 15 mRNA and protein in primary ovarian epithelial carcinomas,and to define the role of P 15 gene in the generation and development of primary ovarian epithelial carcinomas.Methods By using of reverse transcription-polymerase chain reaction (RT-PCR) and immunohistochemistry assays,expressions of P 15 mRNA and protein were detected in 48 primary epithelial ovarian carcinomas and 15 normal ovarian tissues.Results The loss of expressions of P 15 mRNA and P 15 protein was found to be 11 (22.92%) and 13 (27.08%) respectively.Expressions of P 15 mRNA and P 15 protein were detected in all of the 15 normal tissues.There was a correlation between the expressions of P 15 mRNA P 15 protein and histological types in primary epithelial ovarian carcinomas (P<0.05),and although their expressions were irrelevant to FIGO stages and histological grade,there was a tendency for them to increase with the stage and grade increasing.The expression of P 15 at protein level was significantly correlated with that at mRNA level (P<0.05).Conclusions The aberrant expression of P 15 mRNA and protein suggests that inactivation of P 15 gene is associated with tumorigenesis in primary ovarian epithelial carcinomas.
出处 《山东医药》 CAS 北大核心 2004年第24期8-9,共2页 Shandong Medical Journal
关键词 P^15 原发上皮性卵巢癌 RNA 蛋白表达 基因 表达 卵巢组织 RT-PCR 逆转录-聚合酶链反应 失活 Ovarian neoplasms P 15 gene Reverse transcription-polymerase chain reaction Immunohis- tochemistry
  • 相关文献

参考文献3

  • 1Herman JG,Merlo A,Mao L,et al.Inactivation of CDKN2/P16 /MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancer[].Cancer Research.1995
  • 2Herman JG,Latif F,Weng Y,et al.Sliencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma[].Proceedings of the National Academy of Sciences of the United States of America.1994
  • 3Stone S,Dayananth P,Jiang P,et al.Genomic structure, expression and mutational analysis of the P15 gene[].Oncegene.1995

同被引文献6

  • 1姚宏,许彬,张庆昇,平苏萍,赵玛丽,王虹,李新燕.子宫平滑肌肿瘤p16抑癌基因表达的定量研究与临床病理关系[J].山西医药杂志,2004,33(11):935-936. 被引量:1
  • 2黄光辉,储兵.p16和p53基因在乳腺癌和卵巢癌中表达水平的比较研究[J].中国基层医药,2007,14(4):545-546. 被引量:2
  • 3Kamb A, Gruis NA, Weaver-Feldhaus J, et al. A cell cycle regulator potentially involved in genesis of many tumor types [ J]. Science, 1994,264 (5157 ) :436-440.
  • 4Mailer JL. Mitotic control [ J ]. Curt Opin Cell Biol, 1991,3 ( 2 ) : 269-275.
  • 5Hartwell L. Defects in a cell cycle checkpoint may be responsible for the genomic instability of cancer cells [ J ]. Cell, 1992,71 ( 4 ) : 543- 546.
  • 6Kudoh K, Ichikawa Y, Yoshida S, et al. Inactivation of P16/CDKN2 and PIS/MTS2 is associated with prognosis and response to chemotherapy in ovarian cancer [ J ]. Int J Cancer,2002,99 (4) :579-582.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部